FDA's interferon-beta decision reignites orphan debate.
Marshall
A
A
D004345:Drug Industry / Q000331:legislation & jurisprudence; D006801:Humans; D016899:Interferon-beta / Q000096:biosynthesis / Q000627:therapeutic use*; D007880:Legislation, Drug; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration
D016899:Interferon-beta